4GLY image
Deposition Date 2012-08-15
Release Date 2013-05-15
Last Version Date 2024-11-06
Entry Detail
PDB ID:
4GLY
Title:
Human urokinase-type plasminogen activator uPA in complex with the two-disulfide bridge peptide UK504
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Synthetic (Taxon ID: 32630)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.52 Å
R-Value Free:
0.20
R-Value Work:
0.12
R-Value Observed:
0.13
Space Group:
H 3
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Urokinase-type plasminogen activator
Gene (Uniprot):PLAU
Mutagens:C122A, N145Q
Chain IDs:A
Chain Length:245
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:BICYCLIC PEPTIDE INHIBITOR UK504
Chain IDs:B
Chain Length:14
Number of Molecules:1
Biological Source:Synthetic
Peptide-like Molecules
PRD_001039
Primary Citation
Bicyclic Peptide Ligands Pulled out of Cysteine-Rich Peptide Libraries.
J.Am.Chem.Soc. 135 6562 6569 (2013)
PMID: 23560397 DOI: 10.1021/ja400461h

Abstact

Bicyclic peptide ligands were found to have good binding affinity and target specificity. However, the method applied to generate bicyclic ligands based on phage-peptide alkylation is technically complex and limits its application to specialized laboratories. Herein, we report a method that involves a simpler and more robust procedure that additionally allows screening of structurally more diverse bicyclic peptide libraries. In brief, phage-encoded combinatorial peptide libraries of the format X(m)CX(n)CX(o)CX(p) are oxidized to connect two pairs of cysteines (C). This allows the generation of 3 × (m + n + o + p) different peptide topologies because the fourth cysteine can appear in any of the (m + n + o + p) randomized amino acid positions (X). Panning of such libraries enriched strongly peptides with four cysteines and yielded tight binders to protein targets. X-ray structure analysis revealed an important structural role of the disulfide bridges. In summary, the presented approach offers facile access to bicyclic peptide ligands with good binding affinities.

Legend

Protein

Chemical

Disease

Primary Citation of related structures